Managed ventricular pacing and atrial anti-tachycardia pacing for prevention of asymptomatic cerebral infarctio
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0005316
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 120
Patients with age between 18-80 years
AND
- Patients had dual-chamber pacemaker
AND
- Patients had paroxysmal AF (either clinical AF or subclinical AF detected in the intracardiac device > 6 minutes) documented before pacemaker implantation or within 6 months after pacemaker implantation
AND
- Able and willing to provide written informed consent to RFCA and participation in this investigation
- Patients refusing participation in the study.
- Age< 18 years old or > 80 years old
- pregnant woman of child-bearing age with a positive pregnancy test before treatment
- Patients with prior history of ischemic stroke or transient ischemic attack
- Persistent or permanent AF
- Prior PV isolation or surgical ablation of AF or planned for ablation within 3 months
- Patients with acute coronary syndrome or valve surgery within 3 months or planned surgery within 3 months
- Preexisting cardiac implantable device (pacemaker, ICD, or CRT) without ATP function
- Contraindication to the MRI imaging
- Presence of mechanical prosthetic valve
- Significant coronary artery disease requiring coronary intervention, bypass surgery, or continuous antiplatelet therapy
- LV ejection fraction < 35% who indicated for ICD or CRT
- Life expectancy less than 1 year
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method